Page last updated: 2024-10-21

1-aminocyclohexanecarboxylic acid and Benign Neoplasms, Brain

1-aminocyclohexanecarboxylic acid has been researched along with Benign Neoplasms, Brain in 1 studies

1-aminocyclohexanecarboxylic acid: RN given refers to parent cpd
1-amino-1-cyclohexanecarboxylic acid : An alpha-amino acid that is cyclohexanecarboxylic acid substituted by an amino group at position 1.

Research Excerpts

ExcerptRelevanceReference
" In the case of peptide-based radiotracers, the modification and addition of a linker or spacer functional group often offer faster in vivo pharmacokinetic behavior."1.43Improved Pharmacokinetics Following PEGylation and Dimerization of a c(RGD-ACH-K) Conjugate Used for Tumor Positron Emission Tomography Imaging. ( Kim, BI; Kim, JY; Kim, SW; Lee, JW; Lee, KC; Lee, YJ; Park, JA; Shin, UC, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lee, JW1
Lee, YJ1
Shin, UC1
Kim, SW1
Kim, BI1
Lee, KC1
Kim, JY1
Park, JA1

Other Studies

1 other study available for 1-aminocyclohexanecarboxylic acid and Benign Neoplasms, Brain

ArticleYear
Improved Pharmacokinetics Following PEGylation and Dimerization of a c(RGD-ACH-K) Conjugate Used for Tumor Positron Emission Tomography Imaging.
    Cancer biotherapy & radiopharmaceuticals, 2016, Volume: 31, Issue:8

    Topics: Amino Acids, Cyclic; Animals; Brain Neoplasms; Cell Line, Tumor; Copper Radioisotopes; Cyclohexaneca

2016